|
|
Volumn 40, Issue 1, 2001, Pages 63-66
|
|
Dual modulation of UFT with leucovorin and hydroxyurea in metastatic colorectal cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DUAL MODULATION;
DISEASE CONTROL;
PATIENT TREATMENT;
TOXICITY;
TUMORS;
ONCOLOGY;
FLUOROURACIL;
FOLINIC ACID;
HYDROXYUREA;
TEGAFUR;
UFT;
URACIL DERIVATIVE;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BONE MARROW TOXICITY;
CANCER GRADING;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DISEASE-FREE SURVIVAL;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
HYDROXYUREA;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
TEGAFUR;
URACIL;
|
|
EID: 0035076331
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418601750071073 Document Type: Article |
|
Times cited : (7)
|
|
References (13)
|
